JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition'

By: via Benzinga
Shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) are up almost 20 percent over the past five trading sessions. JP Morgan started ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.